ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 90 | -18.2% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 110 | -84.2% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | -5.3% | 698 | -45.2% | 0.00% | -55.6% |
| Q4 2018 | $19,000 | -20.8% | 1,273 | +2.6% | 0.01% | -10.0% |
| Q3 2018 | $24,000 | -35.1% | 1,241 | -5.2% | 0.01% | -37.5% |
| Q2 2018 | $37,000 | +15.6% | 1,309 | -3.6% | 0.02% | +23.1% |
| Q1 2018 | $32,000 | +14.3% | 1,358 | +1.4% | 0.01% | +18.2% |
| Q4 2017 | $28,000 | -28.2% | 1,339 | -19.4% | 0.01% | -47.6% |
| Q3 2017 | $39,000 | +62.5% | 1,662 | +33.1% | 0.02% | +61.5% |
| Q2 2017 | $24,000 | +60.0% | 1,249 | +69.9% | 0.01% | +62.5% |
| Q1 2017 | $15,000 | +1400.0% | 735 | +1212.5% | 0.01% | +700.0% |
| Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | -66.7% | 56 | -60.0% | 0.00% | -50.0% |
| Q1 2016 | $3,000 | -57.1% | 140 | -23.1% | 0.00% | -50.0% |
| Q4 2015 | $7,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |